Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPA | P38571 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21243368 | 0.86 | TP53 (0.38) | TP53CYP3A4EPHX1 | |
| SCHEMBL21243378 | 0.85 | TP53 (0.36) | TP53CYP3A4EPHX1ALDH1A1 | |
| SCHEMBL21243400 | 0.85 | TP53 (0.37) | TP53CYP3A4EPHX1 | |
| SCHEMBL21243351 | 0.84 | TP53 (0.42) | TP53CYP3A4EPHX1ALDH1A1RECQL | |
| SCHEMBL21243330 | 0.84 | TP53 (0.49) | LIPATP53CYP3A4APOBEC3AAPOBEC3G | |
| SCHEMBL21243339 | 0.83 | CYP1A2 (0.37) | TP53CYP3A4ALDH1A1MAPTHTT | |
| SCHEMBL21243380 | 0.81 | TP53 (0.35) | TP53CYP3A4 | |
| SCHEMBL21243371 | 0.81 | TP53 (0.36) | TP53CYP3A4EPHX1 | |
| SCHEMBL21243337 | 0.77 | LIPA (0.39) | LIPATP53CYP3A4APOBEC3AAPOBEC3G | |
| SCHEMBL21243350 | 0.77 | LIPA (0.41) | LIPACYP3A4APOBEC3AAPOBEC3GEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10947472-B2 | Lubricant base oil for power transmission | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2021-03-16 | — | — | US | disclosed |
| US-20190249103-A1 | LUBRICANT BASE OIL FOR POWER TRANSMISSION | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2019-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10947472-B2 | Lubricant base oil for power transmission | DNAH12, DYNC1LI1, DYNC1LI2 | LIPA 1122/4885TP53 4733/4885CYP3A4 4194/4885 |
| US-20190249103-A1 | LUBRICANT BASE OIL FOR POWER TRANSMISSION | DNAH12, DYNC1LI1, DYNC1LI2 | LIPA 1122/4885TP53 4733/4885CYP3A4 4194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.